Crude Oil (CL)

Colgate-Palmolive (NYSE:CL) Bolsa

Colgate-Palmolive

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.

Earnings

Equities

News

Guidance

Movers

General

Las acciones de Colgate-Palmolive bajan tras una caída en las ventas netas del cuarto trimestre, quedando por debajo de las expectativas.

Acciones de Colgate (CL) caen tras resultados del cuarto trimestre: ventas netas por debajo de lo esperado

Colgate-Palmolive Co

Core One Labs Inc

CHINA LIAONING DINGXU ECO by China Liaoning Dingxu Ecological Agriculture Development, Inc.

China Liaoning Dingxu Ecological Agriculture Development Inc

Clarus Corp

CHAVANT CAPITAL ACQUISITION CORP UNIT 1 COM & 1/3 WT EXP

CLARITAS PHARMACICLS INC by CLARITAS PHARMACEUTICALS INC.

Claritas Pharmaceuticals Inc

Core Laboratories Inc

CALBEE Inc

Columbia Financial Inc

CALIBER ENERGY INC by Caliber Energy, Inc.

Colombier Acquisition Corp. II Class A Ordinary Shares

Colombier Acquisition Corp II

Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant

Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share

Cellebrite DI Ltd

CHRISTINA LAKE CANNABIS by Christina Lake Cannabis Corp.

Christina Lake Cannabis Corp

CLICKS GROUP LTD S/ADR by Clicks Group Ltd

Clicks Group Ltd

CENTRAL CHINA SECS S/ADR by Central China Securities Co. Ltd.

Calcol Inc

Sinch AB

Cool Co Ltd

CEL CORP by CEL CORP.

Cell Source Inc

CapitaLand China Trust

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics Inc

Direxion Daily Cloud Computing Bull 2X Shares

Chatham Lodging Trust (REIT) Common Shares of Beneficial Interest

Chatham Lodging Trust

Chatham Lodging Trust (REIT) 6.625% Series A Cumulative Redeemable Preferred Shares of Beneficial Interest

Cloud3 Ventures Inc Ordinary Shares (Sub Voting)

CLOUD3 VENTURES INC by CLOUD3 VENTURES INC

Cloud3 Ventures Inc

Calidi Biotherapeutics Inc Warrants (01/01/9999)

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics Inc

Coles Group Ltd

COLES GROUP LTD UNSP/ADR by Coles Group Ltd.

China Liberal Education Holdings Limited - Ordinary Shares

China Liberal Education Holdings Ltd

CONCRETE LEVELING SYS INC by Concrete Leveling Systems Inc.

Concrete Leveling Systems Inc

Cleveland-Cliffs Inc

Clearfield Inc

CLIFFORD MDERN IVING HLD by CLIFFORD MODERN LIVING HLDGS LTD.

CLARITY METALS CORP by Clarity Metals Corp.

Clarity Metals Corp

Aris Mining Corp

CLEGHORN MINERALS ORD by Cleghorn Minerals

Cleghorn Minerals Ltd

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies Ltd

CLEANGO INNOVATIONS INC by CleanGo Innovations Inc.

CleanGo Innovations Inc

CLEAN SEED CAP GROUP LTD by Clean Seed Capital Group Ltd

Clean Seed Capital Group Ltd

Cloud Nine Web3 Technologies Inc

HUTECH21 CO LTD NEW by Hutech21 Co., Ltd.

Hutech21 Co Ltd

Clean Harbors Inc

ClearDAO

CLST Holdings Inc

COLTENE HOLDING AG ORD by Coltene Holding AG

Coltene Holding AG

Tidal Trust II Veridien Climate Action ETF

Energy Plug Technologies Corp

CORDLIFE GROUP LTD ORD by Cordlife Group Ltd

Cordlife Group Ltd

CLS HOLDINGS PLC ORD by CLS Holdings Plc.

CLS Holdings PLC

Click Holdings Ltd

CAPITALAND INVESTMENT LTD by Capitaland Investment Ltd.

CapitaLand Investment Ltd

CLEAN EARTH ACQUISITIONS CORP RT

CLEAN EARTH ACQUISITIONS CORP UNIT 1 CL A COM & 1 RT 1/2 RED WT EXP

CLEAN EARTH ACQUISITIONS CORP RED WT EXP

Global X Funds Global X 1-3 Month T-Bill ETF

ClearSign Technologies Corporation - Common Stock

ClearSign Technologies Corp

CLEARFORD WATER SYS INC by Clearford Water Systems, Inc.

Clearford Water Systems Inc

CLICKSTREAM CORP by ClickStream Corporation

ClickStream Corp

CITY OF LONDON INVST GRP by City of London Investment Group PLC

City of London Investment Group PLC

ProShares Long Online/Short Stores ETF

Clarke Inc

Calcitech Ltd

TWC ENTERPRISES LTD ORD by TWC Enterprises Ltd.

TWC Enterprises Ltd

CLAYTON & LAMBERT MFG CO by Clayton & Lambert Manufacturing Co.

CHALLENGER GOLD LIMITED by Challenger Gold Limited

Challenger Gold Ltd

COLLINS FOODS LTD NWMKT by Collins Foods Ltd Newmarket Qld

Collins Foods Ltd

BICO Group AB

COLLECTIVE METALS INC by COLLECTIVE METALS INC.

Collective Metals Inc

CELLNEX TELECOM UNSP/ADR by Cellnex Telecom SA

Cellnex Telecom SA

Cellectis S.A. - American Depositary Shares

Cellectis SA

CALLINEX MINES INC by Callinex Mines Inc.

Callinex Mines Inc

Cornerstone Strategic Investment Fund, Inc. Common Shares

Cornerstone Strategic Value Fund Inc

Climb Global Solutions, Inc. - Common Stock

Climb Global Solutions Inc

CALIMA ENERGY LTD NEW by Calima Energy Ltd.

Calima Energy Ltd

CALGRO M3 HOLDINGS LTD by Calgro M3 Holdings Ltd.

Calgro M3 Holdings Ltd

Climeon AB

Climeon AB ass B

CANADIAN PREM SAND by Canadian Prem Sand Inc.

Canadian Premium Sand Inc

Calumet Inc

Clean Energy Fuels Corp

CALIAN GROUP LTD ORD by Calian Group Ltd.

Calian Group Ltd

Clene Inc

NYLI Cleaner Transport ETF

CLEAN VISION CORPORATION by Clean Vision Corporation

Clean Vision Corp

CELLNEX TELECOM SA ORD by Cellnex Telecom SA

Callisto - United States Dollar

iShares AAA CLO Active ETF

CloakCoin

Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) is broadening its footprint in the pet food industry through the purchase of Care TopCo Pty Ltd, the parent company of Prime100, an <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43799390/colgate-palmolive-company-announces-agreement-to-acquire-prime100" rel="noreferrer noopener">Australian fresh pet food brand</a>.
Prime100, founded in 2014 and located in Melbourne, Australia, produces both refrigerated and shelf-stable pet food, which is distributed through pet care retailers and other Australian markets.
The acquisition aligns with the company&#8217;s strategy to tap into rapidly growing markets that complement its main business areas and strengthen its position in Australia&#8217;s pet food market.
By acquiring Prime100, Colgate-Palmolive will enhance its Hill&#8217;s Pet Nutrition division, gaining access to the thriving fresh pet food segment while reinforcing its portfolio of science-based, veterinarian-approved products.
&#8220;Prime100 is a strong, veterinarian-endorsed, premium-priced brand with distinctive positioning that fits well within our long-term pet nutrition growth strategy,&#8221; said Colgate Chairman, President and CEO Noel Wallace.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43791589/why-is-uber-stock-trading-higher-on-tuesday" rel="noreferrer noopener">Uber&#8217;s Ski Service Launches Across Europe: Details</a>
&#8220;We are excited that this acquisition will add a high-growth, profitable fresh dog food asset to the Hill&#8217;s division portfolio with the opportunity to drive continued growth through expanded distribution and awareness.&#8221;
The transaction is set to be completed in the second quarter of 2025, pending regulatory approval in Australia. Colgate plans to fund the deal with a combination of debt and cash.
As of December 31, the company held $1.09 billion in cash and <a target="_blank" href="https://www.benzinga.com/25/01/43385529/colgate-palmolive-posts-mixed-q4-gloomy-outlook" rel="noreferrer noopener">equivalents</a>.&nbsp;The acquisition is not expected to significantly affect its diluted earnings per share in 2025.
Price Action: CL shares closed higher by 0.41% at $86.39 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/02/43791187/costco-travel-taps-travelport-tech-to-upgrade-booking-experience" target="_blank" rel="noreferrer noopener">Costco Travel Taps Travelport Tech To Upgrade Booking Experience</a></li>
</ul>
Photo via Shutterstock.

Large Cap

Colgate-Palmolive Expands Into Fresh Pet Food Market With Prime100 Acquisition

Based in Melbourne, Australia, Prime100 is a fresh pet food brand offering both refrigerated and shelf stable products, sold to pet specialty and other retailers in Australia. Launched in 2014, Prime100 is a leading fresh pet food brand in Australia, driven by its science-backed product lines and veterinary endorsement.
The transaction will be financed with a combination of debt and cash and is currently expected to close in the second quarter of 2025. The acquisition is conditioned upon receipt of regulatory approval in Australia.
The transaction is not expected to have a material impact on diluted earnings per share in 2025.
 &nbsp;

Colgate-Palmolive Agrees To Acquire Care TopCo Pty Ltd, Owner Of Prime100 Pet Food Brand; No Terms Disclosed

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Overweight and lowers the price target from $103 to $97.

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $97

Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) posted mixed results for the fourth <a href="https://www.benzinga.com/quote/CL/earnings">quarter on Friday</a>.
The company reported a fourth-quarter sales decline of 0.12% year-on-year to $4.94 billion, missing the analyst consensus estimate of $4.98 billion. Organic sales increased by 4.3%. Total Oral, Personal, and Home Care net sales decreased by 0.8% to $3.80 billion. Adjusted EPS of 91 cents beat the consensus estimate of 89 cents.
"This was our sixth consecutive year with organic sales growth at or above our 3% to 5% targeted range. The combination of strong sales growth and operating leverage drove strong bottom-line performance as well, with net income and earnings per share both increasing double digits versus 2023," said Chairman, President, and CEO Noel Wallace.
Colgate said it expects FY25 net sales to be roughly flat, including a mid-single-digit negative impact from foreign exchange.
The company expects organic sales growth to be within its long-term targeted range of 3% to 5%, including the impact of the planned exit from private label pet nutrition in 2025.
Colgate-Palmolive shares fell 0.2% to trade at $86.57 on Monday.
These analysts made changes to their price targets on Colgate-Palmolive following earnings announcement.
<ul>
<li>Morgan Stanley analyst Dara Mohsenian maintained Colgate-Palmolive with an Overweight and lowered the price target from $111 to $104.</li>
<li>Raymond James analyst Olivia Tong reiterated Colgate-Palmolive with an Outperform and lowered the price target from $110 to $105.</li>
<li>RBC Capital analyst Nik Modi maintained the stock with a Sector Perform and lowered the price target from $101 to $98.</li>
<li>Stifel analyst Mark Astrachan maintained Colgate-Palmolive with a Hold and lowered the price target from $95 to $93.</li>
<li>UBS analyst Peter Grom maintained the stock with a Buy and cut the price target from $104 to $100.</li>
</ul>
Considering buying CL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="524" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03130429/image-5-1024x524.png" alt="" class="wp-image-763162" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03130429/image-5-1024x524.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03130429/image-5-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03130429/image-5-768x393.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03130429/image-5.png 1143w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43390127/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>

Markets

Trading Ideas

Colgate-Palmolive Analysts Slash Their Forecasts After Q4 Results

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Buy and lowers the price target from $104 to $100.

UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $100

Stifel analyst Mark Astrachan maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Hold and lowers the price target from $95 to $93.

Stifel Maintains Hold on Colgate-Palmolive, Lowers Price Target to $93

RBC Capital analyst Nik Modi maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Sector Perform and lowers the price target from $101 to $98.

RBC Capital Maintains Sector Perform on Colgate-Palmolive, Lowers Price Target to $98

Raymond James analyst Olivia Tong reiterates Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Outperform and lowers the price target from $110 to $105.

Reiteration

Raymond James Reiterates Outperform on Colgate-Palmolive, Lowers Price Target to $105

Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Overweight and lowers the price target from $111 to $104.

Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $104

Major stock indices have completed their recovery following Monday's sharp drop, buoyed by tech stocks rallying on the back of solid earnings <a href="https://www.benzinga.com/news/econ-s">and positive macroeconomic data.</a>
The S&amp;P 500 index stands at 6,118 points at midday trading in New York, not far from the all-time high of 6,128 points reached last Friday.
The Personal Consumption Expenditure price index — the Fed's preferred inflation gauge — <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43390001/feds-favorite-inflation-gauge-rises-as-predicted-consumer-spending-jumps-at-fastest-pace-in-9-months">came in line with expectations in December</a>, easing market participants&#8217; concerns over interest rates. Fed futures continue to reflect expectations for two rate cuts by the end of the year.
Meanwhile, personal spending posted a robust 0.7% increase in December, signaling strong consumer appetite in the final month of the year — a promising sign for corporate earnings.
The Magnificent Seven — as tracked by the Roundhill Magnificent Seven ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NASDAQ">MAGS</a>) – soared 1.6% on Friday, effectively erasing weekly losses after plunging as much as 3.1% on Monday due to the DeepSeek selloff.
Yet, within the elite group, NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) remains 12% lower than last Friday's close, with Friday&#8217;s gains primarily driven by Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)
The Dow Jones, flat on the day, attempted to break its all-time highs at the open but faced resistance from sellers. Sector-wise, tech leads the charge, while energy lags following mixed earnings results from oil giants Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) and Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>).
Gold climbed above $2,800 per ounce, extending new records as demand for the ultimate safe-haven asset surges amid rising geopolitical and trade risks. This comes after President Donald Trump confirmed on Thursday his plan to introduce 25% tariffs on Mexico and Canada starting Feb. 1.
WTI crude oil prices were down 0.3% at $72.3 per barrel, potentially marking their second consecutive weekly decline.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) paused for a breather, holding steady at $104,800.
<h1 class="wp-block-heading">Friday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % chg</td>
</tr>
<tr>
<td>• Nasdaq 100</td>
<td>21,814.96</td>
<td>1.4%</td>
</tr>
<tr>
<td>• S&amp;P 500</td>
<td>6,118.40</td>
<td>0.8%</td>
</tr>
<tr>
<td>• Russell 2000</td>
<td>2,315.94</td>
<td>0.4%</td>
</tr>
<tr>
<td>• Dow Jones</td>
<td>44,973.98</td>
<td>0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:24 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent013125&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;rose 0.7% to $609.38.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) edged up by 0.1% to $449.30.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rallied 1.4% to $530.49.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.5% to $229.68.</li>
<li>The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 1.2%; the Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.7%.</li>
</ul>
<h2 class="wp-block-heading">Friday&#8217;s Stock Movers</h2>
<ul>
<li>Stocks reacting to earning reports included:
<ul>
<li>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), up 0.72%</li>
<li>Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) up 0.80%</li>
<li>Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) up 0.17% </li>
<li>KLA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) up 2.11%, </li>
<li>PPG Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) down 6.12%, </li>
<li>ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) down 6.36%, </li>
<li>Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) up 5.52%, </li>
<li>Deckers Outdoor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) down 16.5%,</li>
<li>LPL Financial Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) up 1.99%.</li>
<li>Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>): down 1.31%</li>
<li>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>): up 6.7%</li>
<li>Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>): down 3.7%</li>
<li>Colgate-Palmolive Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>): down 4.5%</li>
<li>Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>): down 0.8%</li>
<li>Charter Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>): up 3.6%</li>
<li>Booz Allen Hamilton Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>): down 0.6%</li>
</ul>
</li>
</ul>
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43398182/trumps-25-tariffs-could-slaughter-canada-mexico-economies-hit-us-auto-industry-analysts-warn">Trump&#8217;s 25% Tariffs Could Slaughter Canada, Mexico Economies, Hit US Auto Industry, Analysts Warn</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Broad U.S. Equity ETFs

Commodities

Econ #s

Economics

Tech

ETFs

$BTC

AAPL

ABBV

AMZN

CHTR

DECK

SPDR Dow Jones Industrial Average ETF Trust

INTC

KLAC

LPLA

MAGS

NVDA

TSLA

Tech Stocks Rally, S&P 500 Flirts With Records, Gold Extends All-Time Highs: What's Driving Markets Friday?

Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating on the shares of Colgate-Palmolive Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a <a target="_blank" href="https://www.benzinga.com/quote/CL/analyst-ratings" rel="noreferrer noopener">price forecast of $106.</a>
CL reported fourth-quarter earnings per share of $0.91, surpassing expectations (compared to the GS/FactSet consensus of $0.88/$0.89).
However, fourth-quarter organic sales growth of 4.3% fell short of predictions, impacted by a 50 basis point drag from lower private label volumes in Pet Nutrition, said the analyst.
Additionally, Hill&#8217;s Pet Nutrition faced challenges in Europe, leading to a miss in segment growth.
North America&#8217;s organic sales declined by 0.7%, while Europe and APAC experienced low-to-mid single-digit growth. Latin America and Africa/Eurasia saw high single-digit increases, opined the analyst.
Weaker organic sales growth, combined with higher-than-expected inflationary pressures, contributed to lower-than-anticipated gross margins and slightly weaker operating margins.
Also Read: <a href="https://www.benzinga.com//node/43316332">What&#8217;s In The Cards For Walmart This Earnings Season?</a>
According to the analyst, lower tax rate of 21.6% provided a $0.04 EPS boost, contributing to CL&#8217;s small EPS beat for the quarter.
Management has provided its initial FY25 guidance, which largely aligns with expectations, although foreign exchange headwinds are expected to impact net sales and possibly EPS for the year, per the analyst.
The analyst asserted that the company&#8217;s organic sales growth forecast of 3%—5% is consistent with its long-term target. This guidance accounts for the planned exit from private label pet nutrition in 2025, which is expected to have a larger impact than in the fourth quarter.
Overall, the analyst expects the stock to see modest declines due to weaker-than-expected organic sales growth.
The analyst considers CL one of the top-tier companies in the HPC coverage, consistently outperforming and raising its FY24 outlook, even amidst challenging market conditions.
After three years of strong growth, the analyst anticipates a more balanced environment in FY25 with slower price growth and improved volume/mix trends.
However, foreign exchange remains a potential risk, likely impacting gross margins and dollar EPS growth. Looking ahead, the analyst expects the company to maintain healthy revenue growth driven by favorable market trends and market share expansion, benefiting from household penetration and premiumization.
Price Action: CL shares are trading lower by 4.33% at $86.95 at the last check Friday.
Photo via Shutterstock.

Analyst Color

Colgate-Palmolive Remains One Of The Highest-Quality Names Despite Tough End-Market Backdrop: Goldman Sachs

WIIM

Colgate-Palmolive shares are trading lower after the company reported mixed Q4 financial results.

Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) shares are trading lower after the consumer giant reported a fourth-quarter sales decline of 0.12% year-on-year to $4.94 billion, missing the analyst <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43380871/colgate-announces-4th-quarter-and-full-year-2024-results" rel="noreferrer noopener">consensus estimate of $4.98 billion</a>.
Organic sales increased by 4.3%. Total Oral, Personal, and Home Care net sales decreased by 0.8% to $3.80 billion. Adjusted EPS of $0.91 <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">beat the consensus estimate of $0.89.</a>
Gross profit was $2.98 billion, while the margin expanded 70 basis points to 60.3%. Selling, general and administrative expenses rose 5.1% to $1.89 billion.
Operating margin contracted 20 basis points to 21.5%, and operating income for the quarter decreased 0.75% to $1.06 billion.
The company held $1.09 billion in cash and equivalents as of December-end. Operating cash flow for the twelve months totaled $4.1 billion.
&#8220;This was our sixth consecutive year with organic sales growth at or above our 3% to 5% targeted range. The combination of strong sales growth and operating leverage drove strong bottom-line performance as well, with net income and earnings per share both increasing double digits versus 2023,&#8221; said Chairman, President, and CEO Noel Wallace.
Outlook: Colgate expects FY25 net sales to be roughly flat, including a mid-single-digit negative impact from foreign exchange.
The company expects organic sales growth to be within its long-term targeted range of 3% to 5%, including the impact of the planned exit from private label pet nutrition in 2025.
On a non-GAAP (Base Business) basis, the company expects gross profit margin expansion with advertising investment flat to up slightly on both a dollar basis and as a percent to sales and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">low to mid-single-digit earnings-per-share growth.</a>
Price Action: CL shares are trading lower by 2.958% at $88.21 in premarket at the last check Friday. 
Photo via Shutterstock.

Colgate-Palmolive Q4: EPS Beat, Sales Miss, Cautious FY25 Forecast And More

The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%, including the impact of the planned exit from private label pet nutrition over the course of 2025.
On a GAAP basis, the Company expects gross profit margin expansion with advertising investment flat to up slightly on both a dollar basis and as a percent to sales and mid-single-digit earnings-per-share growth.
On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion with advertising investment flat to up slightly on both a dollar basis and as a percent to sales and low to mid-single-digit earnings-per-share growth.

Based On Current Spot Rates, Colgate-Palmolive Expects FY25 Net Sales To Be Roughly Flat, Including Mid-Single-Digit Negative Impact From Foreign Exchange

Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.89 by 2.25 percent. This is a 4.6 percent increase over earnings of $0.87 per share from the same period last year. The company reported quarterly sales of $4.94 billion which missed the analyst consensus estimate of $4.98 billion by 0.71 percent. This is a 0.12 percent decrease over sales of $4.95 billion the same period last year.

Comments

Colgate-Palmolive

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL